Inmune Bio (0Y2) Q2 2024 Earnings Report
DE:0Y2 Q2 2024 EPS Results
- Actual EPS
- -EUR 0.45
- Consensus EPS
- -EUR 0.56
- Beat/Miss
- Beat by +EUR 0.12
- One Year Ago EPS
- -EUR 0.32
DE:0Y2 Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 12.52K
- Beat/Miss
- Missed by -EUR 12.52K
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- After Close
- Conference Call
- Thursday, August 1, 2024
DE:0Y2 Upcoming Earnings
Inmune Bio's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:0Y2 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:0Y2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.13- | -0.21 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.19-0.04 | -0.94 | 95.24% (+0.89) | |
| May 07, 2026 | 2026 (Q1) | -0.22-0.18 | -0.38 | 53.49% (+0.21) | |
| Mar 30, 2026 | 2025 (Q4) | -0.24-0.18 | -0.36 | 50.50% (+0.18) | |
| Oct 30, 2025 | 2025 (Q3) | -0.28-0.21 | -0.54 | 60.00% (+0.32) | |
| Aug 07, 2025 | 2025 (Q2) | -0.34-0.94 | -0.45 | -110.00% (-0.49) | |
| May 08, 2025 | 2025 (Q1) | -0.42-0.38 | -0.55 | 29.51% (+0.16) | |
| Mar 27, 2025 | 2024 (Q4) | -0.49-0.36 | -0.42 | 14.89% (+0.06) | |
| Oct 31, 2024 | 2024 (Q3) | -0.45-0.54 | -0.43 | -25.00% (-0.11) | |
| Aug 01, 2024 | 2024 (Q2) | -0.56-0.45 | -0.32 | -38.89% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
